Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.51 |
| ▸ | ALB | P02768 | 5/20 | 0.50 |
| ▸ | IL2 | P60568 | 5/20 | 0.50 |
| ▸ | MDM4 | O15151 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 3/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.47 |
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
| ▸ | TNF | P01375 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29398014 | 1.00 | FOLH1 (0.51) | FOLH1ALBIL2MDM4TP53 | |
| SCHEMBL29641557 | 1.00 | FOLH1 (0.51) | FOLH1ALBIL2MDM4TP53 | |
| SCHEMBL24489613 | 1.00 | FOLH1 (0.51) | FOLH1ALBIL2MDM4TP53 | |
| SCHEMBL14584328 | 1.00 | FOLH1 (0.51) | FOLH1ALBIL2MDM4TP53 | |
| SCHEMBL29500417 | 0.91 | PTPN1 (0.54) | MDM4TP53PTPN1MDM2SLC17A5 | |
| SCHEMBL29843110 | 0.91 | PTPN1 (0.54) | MDM4TP53PTPN1MDM2SLC17A5 | |
| SCHEMBL9732381 | 0.91 | PTPN1 (0.54) | MDM4TP53PTPN1MDM2SLC17A5 | |
| Catechol SCHEMBL18074826 | 0.90 | PTPN1 (0.53) | MDM4TP53PTPN1MDM2SLC17A5 | |
| SCHEMBL120691 | 0.90 | MDM4 (0.52) | MDM4TP53PTPN1MDM2SLC17A5 | |
| SCHEMBL29401272 | 0.90 | MDM4 (0.52) | MDM4TP53PTPN1MDM2SLC17A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12616761-B2 | CXCR4-targeting compounds | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2026-05-05 | — | — | US | disclosed |
| US-20260036595-A1 | STRUCTURE-BASED PEPTIDES FOR DETECTION OF TRANSTHYRETIN AMYLOID FIBRILS AND AGGREGATES IN PREECLAMPSIA | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-02-05 | — | — | US | disclosed |
| US-20250362310-A1 | STRUCTURE-BASED PROBE FOR DETECTION OF TRANSTHYRETIN AMYLOID FIBRILS AND AGGREGATES | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-11-27 | — | — | US | disclosed |
| US-20240342321-A1 | NOVEL CXCR4-TARGETING COMPOUNDS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2024-10-17 | — | — | US | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| US-20240100203-A1 | NOVEL CXCR4-TARGETING COMPOUNDS | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2024-03-28 | — | — | US | disclosed |
| US-20240067599-A1 | IODOTYROSINE DERIVATIVES AND PROCESS FOR PREPARING IODOTYROSINE DERIVATIVES | ABX ADVANCED BIOCHEMICAL COMPOUNDS - BIOMEDIZINISCHE FORSCHUNGSREAGENZIEN GMBH (DE) | 2024-02-29 | — | — | US | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| US-20230391838-A1 | Conformationally-Constrained Alpha-RGIA Analogues | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2023-12-07 | — | — | US | disclosed |
| EP-4255885-A1 | IODOTYROSINE DERIVATIVES AND PROCESS FOR PREPARING IODOTYROSINE DERIVATIVES | ABX Advanced Biochemical Compounds GmbH (DE) | 2023-10-11 | — | — | EP | disclosed |
| US-20110243845-A1 | SOMATOSTATIN ANALOGS WITH INHIBITORY ACTIVITY TO GROWTH HORMONE RELEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-10-06 | — | — | US | disclosed |
| US-7968080-B2 | Somatostatin analogs with inhibitory activity to growth hormone release | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-06-28 | — | — | US | disclosed |
| US-7968080-B2 | Somatostatin analogs with inhibitory activity to growth hormone release | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-06-28 | — | — | US | disclosed |
| US-7968080-B2 | Somatostatin analogs with inhibitory activity to growth hormone release | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-06-28 | — | — | US | disclosed |
| CN-100475271-C | Somatostatin analogs with inhibitory activity to growth hormone release | UNIV CALIFORNIA (US) | 2009-04-08 | — | — | CN | disclosed |
| US-20070041902-A1 | Somatostatin analogs with inhibitory activity to growth hormone release | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-02-22 | — | — | US | disclosed |
| US-20070041902-A1 | Somatostatin analogs with inhibitory activity to growth hormone release | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-02-22 | — | — | US | disclosed |
| CN-1852742-A | Somatostatin analogs with inhibitory activity to growth hormone release | UNIV CALIFORNIA (US) | 2006-10-25 | — | — | CN | disclosed |
| WO-2005018682-A2 | SOMATOSTATIN ANALOGS WITH INHIBITORY ACTIVITY TO GROWTH HORMONE RELEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-03-03 | — | — | WO | disclosed |
| US-20040014676-A1 | SRC kinase inhibitors useful for treating osteoporosis | ARIAD PHARMACEUTICALS INC. | 2004-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240100203-A1 | NOVEL CXCR4-TARGETING COMPOUNDS | CXCR4, CXCL12, CXCR2 | FOLH1 628/4885ALB 4454/4885IL2 3457/4885 |
| US-20240342321-A1 | NOVEL CXCR4-TARGETING COMPOUNDS | CXCR4, CXCL12, CXCR2 | FOLH1 628/4885ALB 4454/4885IL2 3457/4885 |
| US-20070041902-A1 | Somatostatin analogs with inhibitory activity to growth hormone release | GHRHR, GHSR, SSTR4 | FOLH1 135/4885ALB 1376/4885IL2 2094/4885 |
| US-20240067599-A1 | IODOTYROSINE DERIVATIVES AND PROCESS FOR PREPARING IODOTYROSINE DERIVATIVES | ALK, ALKBH3, INSR | FOLH1 4150/4885ALB 1640/4885IL2 4422/4885 |
| US-12616761-B2 | CXCR4-targeting compounds | CXCR4, CXCR2, CXCR3 | FOLH1 756/4885ALB 3504/4885IL2 2639/4885 |
| US-20040014676-A1 | SRC kinase inhibitors useful for treating osteoporosis | SRC, CTTN, YES1 | FOLH1 4763/4885ALB 4259/4885IL2 4693/4885 |
| US-20110243845-A1 | SOMATOSTATIN ANALOGS WITH INHIBITORY ACTIVITY TO GROWTH HORMONE RELEASE | GHRHR, GHSR, SSTR4 | FOLH1 135/4885ALB 1376/4885IL2 2094/4885 |
| US-20260036595-A1 | STRUCTURE-BASED PEPTIDES FOR DETECTION OF TRANSTHYRETIN AMYLOID FIBRILS AND AGGREGATES IN PREECLAMPSIA | TTR, APP, SERPINA3 | FOLH1 380/4885ALB 76/4885IL2 4149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.